Results 171 to 180 of about 458,490 (361)

AML‐Targeted Metal‐Polyphenol Nanoplatform Induces Ferroptosis‐ICD Cascade for Antitumor Immunity Boosting

Advanced Science, EarlyView.
Schematic illustration of the synthesis protocol for Fe‐SH@Fn, an AML‐targeted nanoplatform engineered to co‐deliver shikonin (SH) and Fe3+, synergistically boosting antitumor immunity via ferroptosis induction and immunogenic cell death (ICD). ABSTRACT Acute myeloid leukemia (AML) remains a therapeutic challenge due to its low immunogenicity and ...
Shangqin Yang, Jingxuan Wang, Kerong Tu, Xiaobing Huang, Liangliang Lv, Mingjie Peng, Qiqi Xu, Hongmei Liu, Qiang Sun, Lulu Cai   +9 more
wiley   +1 more source

FK506 IN CLINICAL ORGAN-TRANSPLANTATION [PDF]

, 1991
ABUELMAGD, K, ARMITAGE, J, BRONSTER, O, FUNG, JJ, GORDON, R, JAIN, A, JORDAN, M, KORMOS, R, MARTIN, M, SELBY, R, SHAPIRO, R, STARZL, TE, STIEBER, A, TODO, S, TZAKIS, A   +14 more
core  

T Cell Exhaustion in Cancer Immunotherapy: Heterogeneity, Mechanisms, and Therapeutic Opportunities

Advanced Science, EarlyView.
T cell exhaustion limits immunotherapy efficacy. This article delineates its progression from stem‐like to terminally exhausted states, governed by persistent antigen, transcription factors, epigenetics, and metabolism. It maps the exhaustion landscape in the TME and proposes integrated reversal strategies, providing a translational roadmap to overcome
Yang Yu, Xiaoyu Yao, Qingyang Wang, Mengrui Yang, Runze Li, Jiangjiang Qin, Jing Zhuang, Changgang Sun   +7 more
wiley   +1 more source

An Implantable Scaffold Sequentially Releasing STING Agonist and B7‐H3 Antibody for Bone Metastasis Immunotherapy

Advanced Science, EarlyView.
We developed an implantable dual‐drug depot using GelMA for bone metastasis treatment, co‐delivering MSA‐2 and αB7‐H3‐loaded CaCO3 microparticles. Sustained release from GelMA scaffold enables MSA‐2 to activate STING signaling and enhance T‐cell infiltration and activation, while sequentially released αB7‐H3 blocks MSA‐2‐induced B7‐H3 upregulation ...
Qijun Lin, Hong Xiao, Shuai Fan, Kaimin Cai, Yanteng Xu, Xinwen Wang, Guanhong Chen, Chuandong Lang, Xinsheng Peng, Mingqiang Li, Yuhu Dai   +10 more
wiley   +1 more source

The immunosuppressive tumor microenvironment in post-transplant lymphoproliferative disorder: pathogenesis and novel therapeutic frontiers. [PDF]

Front Immunol
Dello Strologo A, De Liso C, Scarsella G, Trotta A, Strazza C, Donatone L, Pesce F, Grandaliano G.   +7 more
europepmc   +1 more source

Intestinal and multiple organ transplantation [PDF]

, 2005
Abu-Elmagd, K, Mazariegos, G, Reyes, J, Starzl, TE   +3 more
core  

207P ZEB2 inhibition relieves TAMs-mediated immunosuppression in EGFR-TKI resistant NSCLC [PDF]

Yi Liu, Chao Hu, Ling Cheng, Chao Zhao, Xiaoyang Li, Ming Jiang, Caicun Zhou   +6 more
openalex   +1 more source

Effect of Immunosuppression on the Clinicopathological Changes in Experimental Zygomycosis in Rabbits [PDF]

, 2000
Jatain Sondhi, P. P. Gupta
openalex   +1 more source

Leveraging Macrophage Metabolic Reprogramming for Enhanced Anti‐Tumor Immunity

Advanced Science, EarlyView.
Tumor‐associated macrophages (TAMs) are key regulators of the tumor microenvironment (TME), with their metabolic states playing a critical role in tumor progression or regression. This review summarizes current understanding of TAM metabolic plasticity alongside cutting‐edge bioengineering innovations, outlining a roadmap for transforming the ...
Zhiyun Liu, Lingyao Zeng, Xulin Gan, Yilin Zhou, Han Shen, Dan Wu, Xin Shou, Minmin Jiang, Liyun Shi   +8 more
wiley   +1 more source

Systematic review of emerging technologies in vascularized composite allotransplantation. [PDF]

Front Transplant
Chakradhar A, Yu M, Talbot SG.
europepmc   +1 more source